BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 164873)

  • 1. Diabetogenic activity of deoxy-2-(((ethylnitrosoamino) carbonyl)amino)-D-glucopyranose.
    Anderson T; McMenamin M; Schein PS
    Biochem Pharmacol; 1975 Mar; 24(6):746-7. PubMed ID: 164873
    [No Abstract]   [Full Text] [Related]  

  • 2. New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.
    Kawada J; Toide K; Nishida M; Yoshimura Y; Tsujihara K
    Diabetes; 1986 Jan; 35(1):74-7. PubMed ID: 2934286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of diabetogenic drug activity in the rat: diphenylhydantoin.
    Mackerer CR; Saunders RN; Haettinger JR
    J Toxicol Environ Health; 1976 Sep; 2(1):139-51. PubMed ID: 136521
    [No Abstract]   [Full Text] [Related]  

  • 4. Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
    Schein PS; Cooney DA; McMenamin MG; Anderson T
    Biochem Pharmacol; 1973 Oct; 22(20):2625-31. PubMed ID: 4357891
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood glucose and the histology of the pancreatic islets of Heteropneustes fossilis (Bl.) treated with streptozotocin.
    Khanna SS; Rekhari K
    Acta Anat (Basel); 1973; 85(1):63-8. PubMed ID: 4268273
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Diabetogenic nitrosamines?
    Berne C; Gunnarsson R; Hellerström C; Wilander E
    Lancet; 1974 Feb; 1(7849):173-4. PubMed ID: 4129751
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptozotocin-diabetes in the Chinese hamster. Long-term effects on the light microscopic structure of the pancreatic islet tissue, liver and kidney.
    Wilander E
    Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):767-76. PubMed ID: 4280870
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of diabetogenic drug activity in the rat: 5,5-diphenyl-2-thiohydantoin.
    Mackerer CR; Saunders RN; Haettinger JR; Mehlman MA
    J Toxicol Environ Health; 1977 May; 2(5):1041-51. PubMed ID: 140944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H; Uchigata Y; Okamoto H
    Biochem Biophys Res Commun; 1981 Dec; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative biochemical study on the diabetogenic effect of streptozotocin in mice, rats, Chinese hamsters and guinea pigs].
    Losert W; Rilke A; Loge O; Richter KD
    Arzneimittelforschung; 1971 Nov; 21(11):1643-53. PubMed ID: 4334222
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative morphological studies on the diabetogenic effect of streptozotocin in rats, Chinese hamsters, guinea pigs and rabbits].
    Richter KD; Loge O; Losert W
    Arzneimittelforschung; 1971 Nov; 21(11):1654-6. PubMed ID: 4258515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Streptozotocin].
    Rudas B
    Arzneimittelforschung; 1972 May; 22(5):830-61. PubMed ID: 4340253
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by diphenylhydantoin of the diabetogenic action of streptozotocin.
    Schimmel RJ; Graham D
    Horm Metab Res; 1974 Nov; 6(6):475-7. PubMed ID: 4281411
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
    Lazarus SS; Shapiro SH
    Diabetes; 1973 Jul; 22(7):499-506. PubMed ID: 4146293
    [No Abstract]   [Full Text] [Related]  

  • 17. Islet transplantation into rat liver: in vitro secretion of insulin from the isolated perfused liver and in vivo glucagon suppression.
    Charles MA; Imagawa W; Forsham PH; Grodsky GM
    Endocrinology; 1976 Mar; 98(3):738-42. PubMed ID: 131032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet-cell toxicity.
    Fischer LJ; Rickert DE
    CRC Crit Rev Toxicol; 1975 Jan; 3(2):231-63. PubMed ID: 124241
    [No Abstract]   [Full Text] [Related]  

  • 19. Implicating PARP and NAD+ depletion in type I diabetes.
    Charron MJ; Bonner-Weir S
    Nat Med; 1999 Mar; 5(3):269-70. PubMed ID: 10086377
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetogenic effect of streptozotocin in the rat during the perinatal period.
    Portha B; Levacher C; Picon L; Rosselin G
    Diabetes; 1974 Nov; 23(11):889-95. PubMed ID: 4279194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.